Characterization of the immune cell infiltration landscape in myxofibrosarcoma to aid immunotherapy

Myxofibrosarcoma (MFS) is a highly malignant subtype of soft tissue sarcoma, accounting for 5% of cases. Immunotherapy guided by immune cell infiltration (ICI) is reportedly a promising treatment strategy. Here, MFS samples (n = 104) from two independent databases were classified as ICI clusters A/B...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2022-07, Vol.13, p.916915-916915
Main Authors: Zhao, Zi-Yue, Chen, Zhuo-Yuan, Yu, Bin, Xiao, Bo, Liu, Li-Yan, Xia, Yu, Li, Ao-Yu, Wang, Ping-Xiao, Xiang, Cheng, Liu, Chao, Yang, Hui-Qin, Li, Hui, Xiao, Tao
Format: Article
Language:English
Subjects:
ICI
Immunology
immunotherapy
MFS
prognosis
TME
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Myxofibrosarcoma (MFS) is a highly malignant subtype of soft tissue sarcoma, accounting for 5% of cases. Immunotherapy guided by immune cell infiltration (ICI) is reportedly a promising treatment strategy. Here, MFS samples (n = 104) from two independent databases were classified as ICI clusters A/B/C and gene clusters A/B/C. Then, a close relationship between ICI and gene clusters was established. We found that the features of these clusters were consistent with the characteristics of immune-inflamed tumors (cluster C), immune-desert tumors (cluster B), and immune-excluded tumors (cluster A). Moreover, cluster C was sensitive to immunotherapy. Finally, an independent ICI score was established to predict the therapeutic effect, which has prospects for application in guiding immunotherapy during clinical practice.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.916915